News and Media

A new Yale study investigates how cortisol, a stress-related hormone, helps the brain build emotional memories.

In this episode of The Oprah Podcast, Oprah sits down with Dr. Ania Jastreboff, an endocrinologist and associate professor at the Yale School of Medicine, to talk about the new GLP-1 medications like Ozempic, Wegovy, Mounjaro and Zepbound. Dr. Ania, who has been on the forefront of GLP-1 medication research for the past 20 years, will talk through why it is biologically difficult for some people to lose weight, maintain weight loss, and why obesity is a disease. She explains how the new GLP-1 medications work, how they can facilitate weight loss, and if they are safe. Dr. Ania answers questions from people around the country who are taking the GLP-medications and have lost a significant amount of weight. We will also share an update from Amy Kane who told her story of losing 160 pounds on weight loss medications last year on Oprah’s ABC Special: Shame, Blame and the Weight Loss Revolution.

Rajita Sinha, PhD, Foundations Fund Professor of Psychiatry and Professor in the Child Study Center and of Neuroscience, and director of the Yale Interdisciplinary Stress Center, spoke to The New York Times about the effect of stress on a person's appearance.

A collection of recent studies from YSM

Newly emerging, highly effective treatments and new discoveries regarding the pathophysiology of obesity provide promise for combating this growing epidemic.

WHRY celebrates 25 years of advancing women’s health

The next era of obesity medicine

New anti-obesity medications are transforming the treatment of obesity.

Social stigma harms people with overweight conditions.